NewslettersMesenchymal Cell NewsUmbilical & Placental Cell NewsEndogenous Follistatin-Like 1 Guarantees the Immunomodulatory Properties of Mesenchymal Stem Cells during Liver Fibrotic TherapyBy lbeveridge - August 9, 2022088Investigators characterized the potential role of follistatin-like 1 in MSC-based anti-fibrotic therapy and further elucidated the mechanisms underlying its action.[Stem Cell Research & Therapy]Full Article